Table 2 Patient outcomes after RHCIII-MPC implantation: (A) Clinical outcomes after RHCIII-MPC implantation at last follow-up; (B) Symptoms before surgery and at last follow-up after RHCIII-MPC implantation
A | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient no. | Graft diam. (mm) | Suture removal (weeks after surgery) | Full epithelial coverage (weeks after surgery) | BCVA pre-op LogMAR | BCVA at last follow-up, LogMAR | IOP at last follow-up in the operated eye (mmHg) | IOP at last follow-up fellow eye (mmHg) | Schirmer test at last follow-up operated (mm/5 min) | Schirmer test at last follow-up fellow (mm/5 min) | Corneal pachymetry Pre-op (µm) | Corneal pachymetry at last follow-up (µm) | Neovascularization of implant area at last follow-up | Follow-up (months) |
1 | 6 | 8 | 4 | LP | 0·52 | 17 | 15 | 10 | 15+ | 250 | 470 | No | 24 |
2 | 8 | 3 | 12 | 1.6 | 0.1 | 14 | 12 | 16 | 20 | 484 | 270 | No | 35 |
3* | 8 | 3 | − | 1.6 | 1·0 | NA | NA | NA | NA | 550 | NA | NA | 1.5 |
4 | 7 | 12 | 50 | LP | 1.7 | 13 | 14 | 15+ | 15+ | 1200 | 260 | Yes | 24 |
5 | 5 | 6 | 7 | LP | 1·3 | 19 | 18 | 6 | 10 | 320 | 320 | Yes | 14 |
6 | 4 | 12 | 48 | NLP | NLP | 25 | 15 | 14 | 14 | 410 | 560** | Yes | 24 |
7 | 4 | n/r | 4 | LP | 1.3 | 16 | 16 | 9 | 8 | 220 | 1400 | Yes | 24 |
B | ||||||
|---|---|---|---|---|---|---|
No. | Photophobia / pain | Tearing | Redness | |||
Before | After | Before | After | Before | After | |
1 | + | − | + | − | + | − |
2 | − | − | − | − | − | − |
3 | − | NA | − | − | − | NA |
4 | + | − | + | − | + | − |
5§ | + | − | + | − | + | − |
6 | + | − | + | − | + | − |
7 | + | − | + | − | + | − |
